Clinical Trials Directory

Trials / Completed

CompletedNCT01150747

Chlamydia Trachomatis Immunology and Vaccinology Study

Chlamydia Trachomatis Immunology and Vaccinology Study: Determination of Protective T Cell Responses to Chlamydia Trachomatis Infection

Status
Completed
Phase
Study type
Observational
Enrollment
347 (actual)
Sponsor
Harold Wiesenfeld · Academic / Other
Sex
Female
Age
15 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to prospectively follow 200 women with or at risk of cervicitis to determine the chlamydia-specific cellular responses that correlate with protection against incident infection. The hypothesis is that a positive IFN-y response by peripheral CD4+ T cells responding to stimulation with HSP60 will be significantly associated with protection from incident C. trachomatis infection.

Detailed description

A total of 200 women with or at high risk of having cervicitis will be prospectively followed for correlations between chlamydia-specific cellular responses and protection against incident infection. At enrollment participants will undergo a history and physical examination; blood draw; and pelvic examination including collection of vaginal and cervical samples, STD testing and endometrial biopsy. Participants will have follow up visits conducted at 1, 4, 8 and 12 months following enrollment. At the follow-up visits, participants will undergo a repeat history and physical, blood draw and pelvic examination including collection of vaginal and cervical samples and STD testing. The study design will allow comprehensive identification of the antigen-specific cell mediated immune responses most strongly associated with protection against C. trachomatis infection. The primary objective is to prospectively follow 200 women with or at risk for cervicitis to determine the chlamydia-specific cellular responses that correlate with protection against incident infection.

Conditions

Interventions

TypeNameDescription
DRUGceftriaxone250mg IM once
DRUGAzithromycin1 gm once

Timeline

Start date
2011-01-01
Primary completion
2015-08-01
Completion
2015-08-01
First posted
2010-06-28
Last updated
2015-12-03

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01150747. Inclusion in this directory is not an endorsement.